What is the initial running rate and titration for an 8mg dilution of norepinephrine (Levophed) for a patient with hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Norepinephrine 8mg Dilution: Initial Rate and Titration Protocol

Standard Preparation for 8mg Dilution

Add 8 mg of norepinephrine to 250 mL of D5W to yield a concentration of 32 mcg/mL 1. This is double the standard 4mg/250mL concentration but follows the same dilution principles outlined in the FDA label 1.

Initial Running Rate

Start the infusion at 2-3 mL/hour (approximately 1-1.5 mcg/min or 0.015-0.02 mcg/kg/min for a 70kg adult) 2, 1. The FDA label recommends an initial dose of 2-3 mL per minute of the standard 4 mcg/mL solution (8-12 mcg base per minute) 1, but with your 32 mcg/mL concentration, you must adjust proportionally to achieve the same dosing range.

  • For a 32 mcg/mL concentration, 2-3 mL/hour delivers approximately 1-1.5 mcg/min 1
  • This translates to 0.1-0.5 mcg/kg/min for a 70kg adult, which aligns with guideline recommendations 2, 3

Titration Protocol

Titrate by 0.5-1 mL/hour increments every 5-15 minutes to achieve a target MAP of 65 mmHg 2, 4.

  • Monitor blood pressure and heart rate every 5-15 minutes during initial titration 2
  • Adjust dose to maintain MAP 65-100 mmHg sufficient for vital organ perfusion 3, 4
  • In previously hypertensive patients, raise blood pressure no higher than 40 mmHg below pre-existing systolic pressure 1

Maintenance dosing typically ranges from 0.5-1 mL/hour (1-2 mcg/min or 2-4 mcg base) with your 32 mcg/mL concentration 1. This corresponds to the FDA label's recommended maintenance range of 0.5-1 mL per minute of standard 4 mcg/mL solution 1.

Critical Pre-Administration Requirements

Correct hypovolemia with a minimum 30 mL/kg crystalloid bolus before or concurrent with norepinephrine initiation 2, 4. In severe hypotension (systolic <70 mmHg), start norepinephrine as an emergency measure while fluid resuscitation continues 2.

Administration Route

Use central venous access whenever possible to prevent tissue necrosis from extravasation 2, 3, 1. If central access is unavailable, peripheral IV can be used temporarily with strict monitoring 2.

Monitoring Parameters

  • Hemodynamic targets: MAP ≥65 mmHg 2, 4
  • Tissue perfusion markers: Lactate clearance, urine output >50 mL/h, mental status, capillary refill 2, 4
  • Continuous arterial line monitoring is recommended for all patients requiring vasopressors 3, 4

Escalation Strategy

If norepinephrine reaches 0.25 mcg/kg/min (approximately 8-10 mL/hour with your concentration) and hypotension persists, add vasopressin 0.03-0.04 units/min as second-line therapy 2, 4. Do not continue escalating norepinephrine alone beyond this point 2.

Critical Safety Considerations

If extravasation occurs, immediately infiltrate 5-10 mg of phentolamine diluted in 10-15 mL of saline into the affected site 2, 3, 1. This prevents tissue necrosis and sloughing 2.

  • Do not mix norepinephrine with sodium bicarbonate or alkaline solutions in the IV line, as it becomes inactivated 2
  • Ensure adequate volume resuscitation is occurring concurrently to prevent severe organ hypoperfusion from vasoconstriction in hypovolemic patients 2, 4

References

Guideline

Norepinephrine Drip Administration Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Norepinephrine Dosing for Hypotension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Norepinephrine Dosing and Titration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.